Dr. Reddy's Laboratories launches Reddy-Lenalidomide in Canadian market

02 Sep 2021 Evaluate

Dr. Reddy's Laboratories has launched Reddy-Lenalidomide, a generic equivalent to Revlimid (lenalidomide) capsules in the Canadian market. Reddy-Lenalidomide is one of the first generic medications of its kind to launch in Canada. Reddy-Lenalidomide capsules are available in 2.5 mg, 5 mg, 10 mg, 15 mg, 20 mg, and 25 mg strengths, each in blister packs.

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.

Dr. Reddys Lab Share Price

1202.65 -21.65 (-1.77%)
29-Jan-2026 11:15 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1589.20
Dr. Reddys Lab 1202.65
Cipla 1314.15
Zydus Lifesciences 884.40
Lupin 2102.25
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×